Jubilant Life Sciences has paid the penalty of Rs 5 lakh pursuant to the Securities Appellate Tribunal (SAT) Order on November 22, 2019.
SAT had reduced the penalty on Jubilant Life Sciences to Rs 5 lakh, levied by markets regulator SEBI for violating norms pertaining to price-sensitive information. Earlier, the regulator had imposed a fine of Rs 10 lakh on the firm in January 2018 for making delayed disclosure to the exchanges on various instances regarding price-sensitive information.
Earlier, the regulator had imposed a fine of Rs 10 lakh on the firm in January 2018 for making delayed disclosure to the exchanges on various instances regarding price-sensitive information.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
